Bioassay at Uranium Mills, 35387-35388 [2014-14452]
Download as PDF
35387
Federal Register / Vol. 79, No. 119 / Friday, June 20, 2014 / Notices
The information concerning this
export license amendment application
follows.
NRC EXPORT LICENSE AMENDMENT APPLICATION
Name of applicant, date of
application, date received,
Application No., Docket No.
Cambridge Isotope Laboratories, Inc., May 30, 2014,
June 4, 2014, XMAT426/
01, 11006063.
Description of material
Material type
Deuterium gas, deuterium
oxide, and deuterium
compounds.
For the Nuclear Regulatory Commission.
Dated this 11th day of June 2014 in
Rockville, Maryland.
Michael J. Case,
Acting Deputy Director, Office of
International Programs.
[FR Doc. 2014–14495 Filed 6–19–14; 8:45 am]
BILLING CODE 7590–01–P
NUCLEAR REGULATORY
COMMISSION
[NRC–2012–0057]
Bioassay at Uranium Mills
Nuclear Regulatory
Commission.
ACTION: Regulatory guide; issuance.
AGENCY:
The U.S. Nuclear Regulatory
Commission (NRC) is issuing a revision
to Regulatory Guide (RG) 8.22,
‘‘Bioassay at Uranium Mills.’’ This
guide describes a bioassay program
acceptable to the NRC staff for uranium
mills and applicable portions of
uranium conversion facilities where the
possibility of exposure to yellowcake
dust exists.
ADDRESSES: Please refer to Docket ID
NRC–2012–0057 when contacting the
NRC about the availability of
information regarding this document.
You may access publicly-available
information related to this action by the
following methods:
• Federal Rulemaking Web site: Go to
https://www.regulations.gov and search
for Docket ID NRC–2012–0057. Address
questions about NRC dockets to Carol
Gallagher; telephone: 301–287–3422;
email: Carol.Gallagher@nrc.gov. For
technical questions, contact the
individual(s) listed in the FOR FURTHER
INFORMATION CONTACT section of this
document.
• NRC’s Agencywide Documents
Access and Management System
(ADAMS): You may access publicly
available documents online in the NRC
Library at https://www.nrc.gov/readingrm/adams.html. To begin the search,
select ‘‘ADAMS Public Documents’’ and
mstockstill on DSK4VPTVN1PROD with NOTICES
SUMMARY:
VerDate Mar<15>2010
22:31 Jun 19, 2014
Total quantity
Jkt 232001
End use
Recipient country
10,000 kgs ..........................
Non-nuclear end-use in
medical, pharmaceutical,
chemical, and industrial
markets.
United Arab Emirates.
then select ‘‘Begin Web-based ADAMS
Search.’’ For problems with ADAMS,
please contact the NRC’s Public
Document Room (PDR) reference staff at
1–800–397–4209, 301–415–4737, or by
email to pdr.resource@nrc.gov. The
ADAMS accession number for each
document referenced in this notice (if
that document is available in ADAMS)
is provided the first time that a
document is referenced. Revision 2 of
RG 8.22 is available in ADAMS under
Accession No. ML13350A638. The
regulatory analysis may be found in
ADAMS under Accession No.
ML110960341.
• NRC’s PDR: You may examine and
purchase copies of public documents at
the NRC’s PDR, Room O1–F21, One
White Flint North, 11555 Rockville
Pike, Rockville, Maryland 20852.
Regulatory guides are not
copyrighted, and NRC approval is not
required to reproduce them.
FOR FURTHER INFORMATION CONTACT:
Harriet Karagiannis, telephone: 301–
251–7477, email: Harriet.Karagiannis@
nrc.gov; or Casper Sun, telephone: 301–
251–7912; email: Casper.Sun@nrc.gov.
Both of the Office of Nuclear Regulatory
Research, U.S. Nuclear Regulatory
Commission, Washington, DC 20555–
0001.
SUPPLEMENTARY INFORMATION:
I. Introduction
The NRC is issuing a revision to an
existing guide in the NRC’s ‘‘Regulatory
Guide’’ series. This series was
developed to describe and make
available to the public information such
as methods that are acceptable to the
NRC staff for implementing specific
parts of the agency’s regulations,
techniques that the staff uses in
evaluating specific problems or
postulated accidents, and data that the
staff needs in its review of applications
for permits and licenses.
The NRC issued Revision 2 of RG 8.22
for public comment with a temporary
identification as draft regulatory guide
(DG), DG–8051. This guide describes a
PO 00000
Frm 00078
Fmt 4703
Sfmt 4703
method that the NRC staff considers
acceptable for complying with the
Commission’s regulations concerning
bioassay at uranium mills. It provides
methods that the NRC staff considers
acceptable to implement Part 20 of Title
10 of the Code of Federal Regulations,
(10 CFR), ‘‘Standards for Protection
Against Radiation.’’
II. Additional Information
Draft Regulatory Guide, DG–8051, was
published in the Federal Register on
March 13, 2012 (77 FRN 14837), for a
60-day public comment period. The
public comment period closed on May
11, 2012. Public comments on DG–8051
and the NRC staff’s responses to the
public comments are available in
ADAMS under Accession No.
ML13350A639.
The NRC revised this guide for a
better alignment with: (1) 10 CFR Part
20; (2) the internal dose assessment
recommended by the International
Commission on Radiological Protection
(ICRP), Publication 30, ‘‘Limits for
Intakes of Radionuclides by Workers’’;
and (3) the recommended bioassay
interpretation method by ICRP
Publication 54, ‘‘Individual Monitoring
for Intakes of Radionuclides by Workers:
Design and Interpretation.’’
Regulatory Guide, 8.22, Revision 2
also provides: (1) Recommendations
based on the nephrotoxic analyses in
NUREG–0874, ‘‘Internal Dosimetry
Model for Applications to Bioassay at
Uranium Mills,’’ (Appendix A of the
guide); and (2) the consensus standard
of the American National Standards
Institute/Health Physics Society (ANSI/
HPS) N13.30–2011, ‘‘Performance
Criteria for Radiobioassay,’’ that is
applicable for uranium mills.
III. Congressional Review Act
This RG is a rule as defined in the
Congressional Review Act (5 U.S.C.
801–808). However, the Office of
Management and Budget has not found
it to be a major rule as defined in the
Congressional Review Act.
E:\FR\FM\20JNN1.SGM
20JNN1
35388
Federal Register / Vol. 79, No. 119 / Friday, June 20, 2014 / Notices
IV. Backfitting and Issue Finality
Issuance of this final RG does not
constitute backfitting as defined in 10
CFR 50.109, 70.76, 72.62, or 76.76 and
is not otherwise inconsistent with the
issue finality provisions in 10 CFR Part
52, ‘‘Licenses, Certifications, and
Approvals for Nuclear Power Plants.’’
This final RG provides guidance to
applicants for, and holders of, uranium
milling licenses and some uranium
conversion facility licenses on methods
for meeting certain NRC regulatory
requirements for bioassays in 10 CFR
Part 20.
Licensees may voluntarily use RG
8.22, Revision 2 to demonstrate
compliance with the underlying NRC’s
regulations.
Dated at Rockville, Maryland, this 17th day
of June, 2014.
For the Nuclear Regulatory Commission.
Thomas H. Boyce,
Chief, Regulatory Guidance and Generic
Issues Branch, Division of Engineering, Office
of Nuclear Regulatory Research.
[FR Doc. 2014–14452 Filed 6–19–14; 8:45 am]
BILLING CODE 7590–01–P
PENSION BENEFIT GUARANTY
CORPORATION
Proposed Submission of Information
Collection for OMB Review; Comment
Request; Disclosure of Termination
Information
Pension Benefit Guaranty
Corporation.
ACTION: Notice of intent to request
extension of OMB approval.
AGENCY:
Pension Benefit Guaranty
Corporation (‘‘PBGC’’) intends to
request that the Office of Management
and Budget (‘‘OMB’’) extend approval,
under the Paperwork Reduction Act of
1995, of a collection of information on
the disclosure of termination
information under its regulations for
distress terminations, 29 CFR part 4041,
Subpart C, and for PBGC-initiated
terminations under 29 CFR part 4042
(OMB control number 1212–0065;
expires September 30, 2014). This
notice informs the public of PBGC’s
intent and solicits public comment on
the collection of information.
DATES: Comments should be submitted
by August 19, 2014.
ADDRESSES: Comments may be
submitted by any of the following
methods:
• Federal eRulemaking Portal: https://
www.regulations.gov. Follow the Web
site instructions for submitting
comments.
mstockstill on DSK4VPTVN1PROD with NOTICES
SUMMARY:
VerDate Mar<15>2010
22:31 Jun 19, 2014
Jkt 232001
• Email: paperwork.comments@
pbgc.gov.
• Fax: 202–326–4224.
• Mail or Hand Delivery: Legislative
and Regulatory Department, Pension
Benefit Guaranty Corporation, 1200 K
Street NW., Washington, DC 20005–
4026.
PBGC will make all comments
available on its Web site at
www.pbgc.gov.
Copies of the collection of
information may be obtained without
charge by writing to the Disclosure
Division of the Office of the General
Counsel of PBGC at the above address,
visiting the Disclosure Division, faxing
a request to 202–326–4042, or calling
202–326–4040 during normal business
hours. (TTY and TDD users may call the
Federal relay service toll-free at 1–800–
877–8339 and ask to be connected to
202–326–4040.) The regulations and
instructions relating to this collection of
information are available on PBGC’s
Web site at www.pbgc.gov.
FOR FURTHER INFORMATION CONTACT: Jo
Amato Burns, Attorney, Office of the
General Counsel, Pension Benefit
Guaranty Corporation, 1200 K Street,
NW., Washington, DC 20005, 202–326–
4024. (For TTY and TDD, call 800–877–
8339 and ask to be connected to 202–
326–4024.)
SUPPLEMENTARY INFORMATION: Sections
4041 and 4042 of the Employee
Retirement Income Security Act of 1974,
as amended (‘‘ERISA’’), 29 U.S.C 1301–
1461, govern the termination of singleemployer defined benefit pension plans
that are subject to Title IV of ERISA. A
plan administrator may initiate a
distress termination pursuant to section
4041(c), and PBGC may itself initiate
proceedings to terminate a pension plan
under section 4042 if PBGC determines
that certain conditions are present.
Section 506 of the Pension Protection
Act of 2006 amended sections 4041 and
4042 of ERISA. These amendments
require that, upon a request by an
affected party, a plan administrator
must disclose information it has
submitted to PBGC in connection with
a distress termination filing, and that a
plan administrator or plan sponsor must
disclose information it has submitted to
PBGC in connection with a PBGCinitiated termination. The provisions
also require PBGC to disclose the
administrative record relating to a
PBGC-initiated termination upon
request by an affected party.
A description of the current
disclosure provisions for distress
terminations can be found on PBGC’s
Web site at www.pbgc.gov/Documents/
PO 00000
Frm 00079
Fmt 4703
Sfmt 4703
Disclosure_of_Distress_Termination_
Information.pdf.
PBGC estimates that three participants
or other affected parties will annually
make requests for termination
information. PBGC estimates that the
total annual burden for the collection of
information will be about 45 hours and
$900 (15 hours and $300 per request).
PBGC is soliciting public comments
to—
• Evaluate whether the collection of
information is necessary for the proper
performance of the functions of the
agency, including whether the
information will have practical utility;
• Evaluate the accuracy of the
agency’s estimate of the burden of the
collection of information, including the
validity of the methodology and
assumptions used;
• Enhance the quality, utility, and
clarity of the information to be
collected; and
• Minimize the burden of the
collection of information on those who
are to respond, including the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms of
information technology, e.g., permitting
electronic submission of responses.
Issued in Washington, DC, this 16th day of
June, 2014.
Judith Starr,
General Counsel, Pension Benefit Guaranty
Corporation.
[FR Doc. 2014–14462 Filed 6–19–14; 8:45 am]
BILLING CODE 7709–02–P
POSTAL REGULATORY COMMISSION
[Docket Nos. MC2014–27 and CP2014–53;
Order No. 2092]
New Postal Product
Postal Regulatory Commission.
Notice.
AGENCY:
ACTION:
The Commission is noticing a
recent Postal Service filing requesting
the addition of Priority Mail Express,
Priority Mail & First-Class Package
Service Contract 3 to the competitive
product list. This notice informs the
public of the filing, invites public
comment, and takes other
administrative steps.
DATES: Comments are due: June 24,
2014.
ADDRESSES: Submit comments
electronically via the Commission’s
Filing Online system at https://
www.prc.gov. Those who cannot submit
comments electronically should contact
the person identified in the FOR FURTHER
INFORMATION CONTACT section by
SUMMARY:
E:\FR\FM\20JNN1.SGM
20JNN1
Agencies
[Federal Register Volume 79, Number 119 (Friday, June 20, 2014)]
[Notices]
[Pages 35387-35388]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-14452]
-----------------------------------------------------------------------
NUCLEAR REGULATORY COMMISSION
[NRC-2012-0057]
Bioassay at Uranium Mills
AGENCY: Nuclear Regulatory Commission.
ACTION: Regulatory guide; issuance.
-----------------------------------------------------------------------
SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) is issuing a
revision to Regulatory Guide (RG) 8.22, ``Bioassay at Uranium Mills.''
This guide describes a bioassay program acceptable to the NRC staff for
uranium mills and applicable portions of uranium conversion facilities
where the possibility of exposure to yellowcake dust exists.
ADDRESSES: Please refer to Docket ID NRC-2012-0057 when contacting the
NRC about the availability of information regarding this document. You
may access publicly-available information related to this action by the
following methods:
Federal Rulemaking Web site: Go to https://www.regulations.gov and search for Docket ID NRC-2012-0057. Address
questions about NRC dockets to Carol Gallagher; telephone: 301-287-
3422; email: Carol.Gallagher@nrc.gov. For technical questions, contact
the individual(s) listed in the FOR FURTHER INFORMATION CONTACT section
of this document.
NRC's Agencywide Documents Access and Management System
(ADAMS): You may access publicly available documents online in the NRC
Library at https://www.nrc.gov/reading-rm/adams.html. To begin the
search, select ``ADAMS Public Documents'' and then select ``Begin Web-
based ADAMS Search.'' For problems with ADAMS, please contact the NRC's
Public Document Room (PDR) reference staff at 1-800-397-4209, 301-415-
4737, or by email to pdr.resource@nrc.gov. The ADAMS accession number
for each document referenced in this notice (if that document is
available in ADAMS) is provided the first time that a document is
referenced. Revision 2 of RG 8.22 is available in ADAMS under Accession
No. ML13350A638. The regulatory analysis may be found in ADAMS under
Accession No. ML110960341.
NRC's PDR: You may examine and purchase copies of public
documents at the NRC's PDR, Room O1-F21, One White Flint North, 11555
Rockville Pike, Rockville, Maryland 20852.
Regulatory guides are not copyrighted, and NRC approval is not
required to reproduce them.
FOR FURTHER INFORMATION CONTACT: Harriet Karagiannis, telephone: 301-
251-7477, email: Harriet.Karagiannis@nrc.gov; or Casper Sun, telephone:
301-251-7912; email: Casper.Sun@nrc.gov. Both of the Office of Nuclear
Regulatory Research, U.S. Nuclear Regulatory Commission, Washington, DC
20555-0001.
SUPPLEMENTARY INFORMATION:
I. Introduction
The NRC is issuing a revision to an existing guide in the NRC's
``Regulatory Guide'' series. This series was developed to describe and
make available to the public information such as methods that are
acceptable to the NRC staff for implementing specific parts of the
agency's regulations, techniques that the staff uses in evaluating
specific problems or postulated accidents, and data that the staff
needs in its review of applications for permits and licenses.
The NRC issued Revision 2 of RG 8.22 for public comment with a
temporary identification as draft regulatory guide (DG), DG-8051. This
guide describes a method that the NRC staff considers acceptable for
complying with the Commission's regulations concerning bioassay at
uranium mills. It provides methods that the NRC staff considers
acceptable to implement Part 20 of Title 10 of the Code of Federal
Regulations, (10 CFR), ``Standards for Protection Against Radiation.''
II. Additional Information
Draft Regulatory Guide, DG-8051, was published in the Federal
Register on March 13, 2012 (77 FRN 14837), for a 60-day public comment
period. The public comment period closed on May 11, 2012. Public
comments on DG-8051 and the NRC staff's responses to the public
comments are available in ADAMS under Accession No. ML13350A639.
The NRC revised this guide for a better alignment with: (1) 10 CFR
Part 20; (2) the internal dose assessment recommended by the
International Commission on Radiological Protection (ICRP), Publication
30, ``Limits for Intakes of Radionuclides by Workers''; and (3) the
recommended bioassay interpretation method by ICRP Publication 54,
``Individual Monitoring for Intakes of Radionuclides by Workers: Design
and Interpretation.''
Regulatory Guide, 8.22, Revision 2 also provides: (1)
Recommendations based on the nephrotoxic analyses in NUREG-0874,
``Internal Dosimetry Model for Applications to Bioassay at Uranium
Mills,'' (Appendix A of the guide); and (2) the consensus standard of
the American National Standards Institute/Health Physics Society (ANSI/
HPS) N13.30-2011, ``Performance Criteria for Radiobioassay,'' that is
applicable for uranium mills.
III. Congressional Review Act
This RG is a rule as defined in the Congressional Review Act (5
U.S.C. 801-808). However, the Office of Management and Budget has not
found it to be a major rule as defined in the Congressional Review Act.
[[Page 35388]]
IV. Backfitting and Issue Finality
Issuance of this final RG does not constitute backfitting as
defined in 10 CFR 50.109, 70.76, 72.62, or 76.76 and is not otherwise
inconsistent with the issue finality provisions in 10 CFR Part 52,
``Licenses, Certifications, and Approvals for Nuclear Power Plants.''
This final RG provides guidance to applicants for, and holders of,
uranium milling licenses and some uranium conversion facility licenses
on methods for meeting certain NRC regulatory requirements for
bioassays in 10 CFR Part 20.
Licensees may voluntarily use RG 8.22, Revision 2 to demonstrate
compliance with the underlying NRC's regulations.
Dated at Rockville, Maryland, this 17th day of June, 2014.
For the Nuclear Regulatory Commission.
Thomas H. Boyce,
Chief, Regulatory Guidance and Generic Issues Branch, Division of
Engineering, Office of Nuclear Regulatory Research.
[FR Doc. 2014-14452 Filed 6-19-14; 8:45 am]
BILLING CODE 7590-01-P